Conformis
Customized Partial & Total Knee Replacements.
Launch date
Employees
Market cap
€16.2m
Enterprise valuation
€17m (Public information from Sep 2023)
Share price
$2.26 CFMS
Billerica Massachusetts (HQ)
Financials
Estimates*
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 78.1m | 89.8m | 77.4m | 68.8m | 99.9m | 62.1m | 76.0m |
% growth | - | 15 % | (14 %) | (11 %) | 45 % | (38 %) | 22 % |
EBITDA | (47.6m) | (35.8m) | (24.8m) | (25.0m) | 4.3m | (46.2m) | (27.0m) |
% EBITDA margin | (61 %) | (40 %) | (32 %) | (36 %) | 4 % | (74 %) | (36 %) |
Profit | (53.6m) | (43.4m) | (28.5m) | (24.3m) | (2.4m) | (50.5m) | (39.0m) |
% profit margin | (69 %) | (48 %) | (37 %) | (35 %) | (2 %) | (81 %) | (51 %) |
EV / revenue | 1.2x | 0.2x | 1.3x | 1.1x | 1.1x | 1.8x | - |
EV / EBITDA | -1.9x | -0.6x | -4.2x | -3.2x | 25.3x | -2.4x | - |
R&D budget | 17.1m | 16.9m | 12.5m | 11.9m | 14.8m | 15.3m | - |
R&D % of revenue | 22 % | 19 % | 16 % | 17 % | 15 % | 25 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$10.2m | Series B | ||
$12.1m | Series C | ||
$10.0m | Debt | ||
$14.9m | Series D | ||
$50.0m | Series D | ||
$1.4m | Debt | ||
$89.0m | Series E | ||
$168m | Series E | ||
N/A | N/A | IPO | |
$50.0m | Debt | ||
$30.0m | Post IPO Debt | ||
N/A | $3.0m | Post IPO Equity | |
N/A | $85.0m | Post IPO Equity | |
* | N/A | Acquisition | |
Total Funding | €313m |
Related Content
Recent News about Conformis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.